TSE:TSU

Trisura Group (TSU.TO)

42.70
+0.06 (0.14%)
as of Jun 9, 2026, 8:00:00 pm Market Open.
102 watching
0
Investor Insights
star iconJun 10, 2026, 12:00 am

This summary was created by AI, based on 5 opinions in the last 12 months.

Trisura Group is recognized as a leading specialty insurer in Canada, boasting approximately 30% market share and aggressively expanding into the U.S. market, particularly in surety and property insurance. Analysts note that despite facing pressure due to past asset impairments and a hardening insurance market, there is significant potential for turnaround and earnings growth. The company has demonstrated a high return on equity (ROE) and impressive book value per share growth, which is expected to continue. With a solid cash position, Trisura is viewed as an attractive takeout candidate amidst its high-quality management. Although it has faced challenges, many experts believe it represents an appealing investment opportunity at its current valuation.

consensus icon
Consensus
Positive
valuation icon
Valuation
Undervalued
review icon
Similar
SLF,TSU
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly We reiterate TSU, a specialty insurance company focusing on surety bonds, corporate and fee based insurance services as a TOP PICK. The company recently acquired another Canadian surety business, which will be accretive to earnings. We recommend trailing up the stop (from $26) to $31, looking to achieve $56 -- upside potential over 45%. Yield 0% (Analysts’ price target is $56.29)
BUY
Insurer that operates in Canada and US. Great business. Growing rapidly, which generates more capital. Strong quarters, with one hiccup. Once the market stabilizes, he sees stock at $40+. Add at these levels.
premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O'Reilly This specialty insurance company, focusing on surety bonds, corporate and fee based insurance services, recently reported earnings 30% above analyst expectations and a ROE over 27%. It has a conservative balance sheet supported by an investment grade rating. Expectations are that next years earnings will be another 50% higher. Forward PE is projected at 16x earnings. We recommend setting a stop loss at $26, looking to achieve $46 -- upside potential over 30%. Yield 0% (Analysts’ price target is $56.00)
PAST TOP PICK
(A Top Pick Jun 09/21, Up 3%) Would buy shares in the company again & continues to hold. Very impressed with management team and return on equity metrics. Company has recently raised $150 MM. Very good quarter with earnings and performance.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. A relatively small insurance company that has good growth and market share gains. Playing in a fragmented market and they could acquire more companies. Better upside than larger insurers like Sunlife and Manulife. Unlock Premium - Try 5i Free

BUY ON WEAKNESS
An insurance company. Cashflow has been through their PnC insurance business in Canada. This has funded the specialty insurance in the US. A spin-off of BAM.A. A fantastic company that is growing 50%+ and it is expected to continue with a mix of organic and acquisitions.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company reported strong earnings results. EPS beat estimates at $0.38 and revenues were $404.68M. Revenues also grew by 68.9% yoy. Very strong results that should make investors happy. The company is cheap relative to results. Unlock Premium - Try 5i Free

BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. TSU reported an EPS of $0.35 that beat expectations by 6 cents. Gross premiums written had good growth and ROE for the quarter was strong at 18.3%. Unlock Premium - Try 5i Free

TOP PICK
Specialty insurance. Spun out of one of the Brookfields. US business, called fronting, is very exciting, and it crosses state lines. Growth profile is fantastic. High and growing ROEs, growing access to capital, dynamic CEO. No dividend. (Analysts’ price target is $178.13)
TOP PICK
A spin-off of Brookfield Asset Management. For every 170 shares of BAM-T one owned, they received one share of TSU-T. They underwrite smaller BTB insurance. They can sell-off re-insurance for a recurring fee stream in the US – a process called “fronting”. On paper it looks like they operate at a loss, but it will be prove up in time. Yield 0%. (Analysts’ price target is $32.00)
Showing 31 to 40 of 40 entries